Bank of New York Mellon’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
|
|||||
|
2025
Q1 | $15M | Sell |
|
|||||
|
2024
Q4 | $25.3M | Sell |
|
|||||
|
2024
Q3 | $38.8M | Sell |
|
|||||
|
2024
Q2 | $35.8M | Sell |
|
|||||
|
2024
Q1 | $36.5M | Sell |
|
|||||
|
2023
Q4 | $40.1M | Sell |
|
|||||
|
2023
Q3 | $40.5M | Sell |
|
|||||
|
2023
Q2 | $58.7M | Sell |
|
|||||
|
2023
Q1 | $46.5M | Buy |
|
|||||
|
2022
Q4 | $55.8M | Buy |
|
|||||
|
2022
Q3 | $58.2M | Buy |
|
|||||
|
2022
Q2 | $55M | Buy |
|
|||||
|
2022
Q1 | $51.8M | Buy |
|
|||||
|
2021
Q4 | $41.6M | Buy |
|
|||||
|
2021
Q3 | $19M | Buy |
|
|||||
|
2021
Q2 | $27.2M | Buy |
|
|||||
|
2021
Q1 | $14.9M | Sell |
|
|||||
|
2020
Q4 | $36.8M | Sell |
|
|||||
|
2020
Q3 | $26.1M | Buy |
|
|||||
|
2020
Q2 | $15.6M | Buy |
|
|||||
|
2020
Q1 | $6.02M | Buy |
|
|||||
|
2019
Q4 | $5.86M | Sell |
|
|||||
|
2019
Q3 | $5.19M | Buy |
|
|||||
|
2019
Q2 | $4.71M | Sell |
|
|||||
|
2019
Q1 | $5.3M | Buy |
|
|||||
|
2018
Q4 | $4.7M | Buy |
|
|||||
|
2018
Q3 | $4.43M | Buy |
|
|||||
|
2018
Q2 | $933K | Buy |
|
|||||
|
2018
Q1 | $1.03M | Buy |
|